Study to Evaluate the Efficacy of Zanzalintinib in the Treatment of Relapsed or Metastatic Adenoid Cystic Carcinomas of the Head and Neck

NCT07682675 · clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
51
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

UNICANCER